{"meta":{"query_hash":"3aa0d18681ac","filters":{"venue":"Giornale Italiano di Health Technology Assessment"},"cohort_total":1,"direct_labels_cover":0,"predictions_cover":1,"exported":1,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/3aa0d18681ac","api":"https://metacan.xera.ac/api/v1/cohort?venue=Giornale+Italiano+di+Health+Technology+Assessment"},"results":[{"id":"W143705049","doi":"10.1007/bf03320739","title":"Una valutazione economica degli agenti stimolanti l’eritropoiesi nel trattamento dell’anemia indotta da chemioterapia in Italia","year":2011,"lang":"it","type":"article","venue":"Giornale Italiano di Health Technology Assessment","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Amgen (Canada)","funders":"","keywords":"Darbepoetin alfa; Epoetin alfa; Medicine; Anemia; Clinical trial; Economic evaluation; Internal medicine","score_opus":0.05851724402473276,"score_gpt":0.3475862953942281,"score_spread":0.28906905136949534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W143705049","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.26359972,0.5262799,0.013202768,0.13553753,0.002320713,0.0004906873,0.00840293,0.00008259827,0.050083127],"genre_scores_gemma":[0.8559198,0.12024795,0.0070034135,0.004233963,0.00160154,0.00040225347,0.0020094758,0.000030920666,0.008550659],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966529,0.0025010903,0.00013636133,0.00015109795,0.0004179084,0.00014071338],"domain_scores_gemma":[0.99500495,0.0036242167,0.0006089809,0.00017036143,0.00037624536,0.00021528309],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046794745,0.00039934253,0.0006620608,0.0009641677,0.000108146254,0.0014965058,0.00027810122,0.0007779103,0.0052070506],"category_scores_gemma":[0.010179454,0.0001540875,0.0012002491,0.0011279124,0.00042467914,0.0005582974,0.0003702551,0.0012071617,0.00035553452],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028776627,0.00077604095,0.05086287,0.0042572413,0.0054639666,0.00042638255,0.00014606694,0.038248196,0.0040164813,0.03750358,0.031666424,0.79785615],"study_design_scores_gemma":[0.016155912,0.015359691,0.34857652,0.015667206,0.015795777,0.0018797634,0.0005303542,0.067572095,0.010416692,0.050951727,0.45689282,0.00020139807],"about_ca_topic_score_codex":0.0038563637,"about_ca_topic_score_gemma":0.0032640935,"teacher_disagreement_score":0.0052070506,"about_ca_system_score_codex":0.0032542755,"about_ca_system_score_gemma":0.0027346173,"threshold_uncertainty_score":0.02474773},"labels":[],"label_agreement":null}]}